Mitsui Chemicals acquires Heraeus Dental for €450 million (US$578 million)

Client(s) Mitsui Chemicals Inc.

Jones Day advised Mitsui Chemicals, Inc. in its acquisition of the dental business of Heraeus Holding GmbH for €450 million (US$578 million). Mitsui Chemicals is a Japanese publicly traded chemical company with 13,000 employees worldwide. Based in Hanau near Frankfurt am Main, Heraeus is a global precious metal and technology group that also employs about 13,000 people.

The dental business has approximately 1,400 employees at 20 locations in Europe, the Americas, and Asia. Their product offering includes prosthetics and systems for the conservation and restoration of natural teeth, and an extensive range of products for dental laboratories and dentists. Mitsui Chemicals' subsidiary Sun Medical has been involved in the dental materials business for more than 30 years and has a strong presence in the Japanese domestic market. The acquisition of the Heraeus dental business gives Mitsui Chemicals access to a global platform for its dental materials business and accelerates its future growth.

Jones Day has a long history of advising Mitsui Chemicals on cross-border transactions, including its recent acquisition of Swiss based Acomon AG, a leading producer of optical monomers. For this transaction, the company relied on lawyers in the Firm's Tokyo, Frankfurt, Munich, Amsterdam, London, Milan, Paris, Cleveland, New York, Mexico City, Sao Paulo, and Sydney offices. In addition to M&A representation, Jones Day provided real estate, intellectual property, antitrust, labor, and employee benefits advice regarding this transaction.